Home
/
Records
/
Fda Inspections
/
Recipharm Uppsala AB

FDA Inspection

•Recipharm Uppsala AB•April 17, 2024

FDA Inspection 1301930 - Recipharm Uppsala AB - April 17, 2024

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Recipharm Uppsala AB, with an inspection on April 17, 2024, covering drugs.

Company: Recipharm Uppsala AB
Inspection Date: April 17, 2024
Product Type: Drugs

Open in Dashboard

ID · 3eaa37b0-c60d-42c2-962d-34d43dbbe3cf

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

[email protected]

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA Inspection 1301930 - Recipharm Uppsala AB - April 17, 2024 | Global Key Solutions